In humans, the endometrium, the uterine mucosal lining, undergoes dynamic changes throughout the menstrual cycle and pregnancy. Despite the importance of the endometrium as the site of implantation and nutritional support for the conceptus, there are no long-term culture systems that recapitulate endometrial function in vitro. We adapted conditions used to establish human adult stem-cell-derived organoid cultures to generate three-dimensional cultures of normal and decidualized human endometrium. These organoids expand long-term, are genetically stable and differentiate following treatment with reproductive hormones. Single cells from both endometrium and decidua can generate a fully functional organoid. Transcript analysis confirmed great similarity between organoids and the primary tissue of origin. On exposure to pregnancy signals, endometrial organoids develop characteristics of early pregnancy. We also derived organoids from malignant endometrium, and so provide a foundation to study common diseases, such as endometriosis and endometrial cancer, as well as the physiology of early gestation.
In humans, the endometrium, the uterine mucosal lining, undergoes dynamic changes throughout the menstrual cycle and pregnancy. Despite the importance of the endometrium as the site of implantation and nutritional support for the conceptus, there are no long-term culture systems that recapitulate endometrial function in vitro. We adapted conditions used to establish human adult stem-cell-derived organoid cultures to generate three-dimensional cultures of normal and decidualized human endometrium. These organoids expand long-term, are genetically stable and differentiate following treatment with reproductive hormones. Single cells from both endometrium and decidua can generate a fully functional organoid. Transcript analysis confirmed great similarity between organoids and the primary tissue of origin. On exposure to pregnancy signals, endometrial organoids develop characteristics of early pregnancy. We also derived organoids from malignant endometrium, and so provide a foundation to study common diseases, such as endometriosis and endometrial cancer, as well as the physiology of early gestation.
Throughout adult reproductive life, the functional layer of the human endometrium undergoes a monthly cycle of regeneration, differentiation and shedding under the control of the hypothalamicpituitary-ovarian axis. The mucosa contains simple glands lined by secretory columnar epithelium, separated by intervening stroma. During the oestrogen-dominated proliferative phase that follows menstruation, the mucosa regrows and then differentiates during the progesterone-dominated secretory phase. Implantation occurs ∼7 days post-ovulation onto the ciliated luminal epithelium and stimulates transformation into the gestational endometrium, the true decidua of pregnancy, that provides a microenvironment essential for placentation. Up to ∼10 weeks of gestation, uterine glands provide histotrophic nutrition for the conceptus before the definitive haemochorial placenta is established 1, 2 . Animal models in mice and ruminants where glandular function is suppressed are unable to support implantation and pregnancy 3, 4 . Such models have revealed the molecular interactions involved between the trophectoderm and the uterine surface, and the key cytokines secreted by the glands, such as leukaemia inhibitory factor 5 . However, the composition of the secretions, and the gland/conceptus signalling dialogue during human placentation are unknown due to their inaccessibility in vivo and the absence of in vitro models. Suboptimal glandular development and/or functions may result in human pregnancy failure or predispose to complications of later pregnancy, such as growth restriction 6 . Thus, model systems to study these essential processes of human early pregnancy would have many biological and clinical applications.
Although stem/progenitor cells within the stromal compartment of the endometrium have been identified, suitable markers for glandular progenitors are unknown 7 . In mice, stem cells are probably present at the base of the glands 8 ; similarly in primates, cells in the basal layer that is not shed during menstruation can generate both glandular and luminal epithelia 9, 10 . In humans, putative endometrial stem cells are the SSEA-1 + , SOX9 + population with clonogenic ability 11,12 but these are not fully characterized and it is unknown how they maintain uterine glands. Previous culture systems of human endometrial glandular cells, including three-dimensional (3D) cultures, do not fully recapitulate glandular features in vivo, and are not long-term or chemically defined 13, 14 . Establishing defined endometrial organoid cultures will offer possibilities for studying events during implantation and early pregnancy in vitro as human blastocysts can be cultured past the implantation phase of development 15, 16 . Organoids are self-organizing, genetically stable, 3D culture systems containing both progenitor/stem and differentiated cells that resemble the tissue of origin. Human organoids have been derived from tissue-resident adult epithelial stem cells from gut, liver, pancreas, prostate and fallopian tube [17] [18] [19] [20] [21] . We have now generated long-term, chemically defined 3D glandular organoid cultures from non-pregnant endometrium and decidua. The organoids recapitulate features of uterine glands in vivo; the ability to respond to hormonal signals, secrete components of 'uterine milk' and differentiate into ciliated luminal epithelial cells. Human endometrial organoids can be used to answer questions about uterine/placental cross-talk during placentation, and will provide a system for studying the pathogenesis and treatment of common conditions affecting women, such as endometriosis and endometrial cancer.
RESULTS
Long-term genetically stable 3D organoid cultures can be established from human non-pregnant endometrium and decidua To generate endometrial organoids, we used tissue isolates enriched for epithelial cells, and allowed these to self-organize within Matrigel droplets with the basal medium that supports development of other human tissue organoids, containing EGF, Noggin and R-spondin-1 (ENR) (Fig. 1a) . Because the signalling pathways maintaining endometrial gland stem/progenitor cells are unknown, we tested factors secreted by surrounding stromal cells, FGF10 and HGF [22] [23] [24] [25] . Nicotinamide and the Alk3/4/5 inhibitor, A83-01, that blocks the TGFβ pathway were added as they are crucial in the establishment and/or long-term culture of other human organoid systems 18, 20, 26 . Decidual samples were initially used to optimize the culture conditions as they yield high cell numbers. Glandular cells were cultured for 7 days and passaged at 1:3. Organoid numbers were counted after another 7 days (Fig. 1b,c) . A83-01, FGF10 and HGF with EGF, Noggin, R-spondin-1 and nicotinamide, expansion medium (ExM), gave the highest yield of organoids (Fig. 1c, C8) .
Organoid cultures were established in ExM within 1-2 passages (Fig. 1d) . To assess the requirement for each culture component, 5,000 cells were plated from established cultures (grown for >4 passages) in the absence of each factor, and the number of spheroids present after one week was counted. Withdrawal of nicotinamide had the strongest effect, whilst the lack of Noggin, R-spondin-1, A83-01, EGF and HGF resulted in reduced numbers and/or smaller organoids ( Fig. 1e and Supplementary Fig. 1a ). FGF10 was maintained in the medium, even though it had no effect on size or numbers of organoids (Fig. 1e) , because it was important initially in establishing cultures and provides a physiological environment (Fig. 1b) . ENR, A83-01 and nicotinamide will maintain established cultures, but were not tested in differentiation experiments and long-term culture ( Supplementary Fig. 1b ). Organoid cultures were robustly established from decidual samples in ExM from 25/26 donors (derivation efficiency of 96%). Organoids were then successfully generated from non-pregnant secretory endometrium with 100% derivation efficiency (11/11) (Fig. 1f) . Proliferative phase endometrium is infrequently sampled, but we did generate organoids from this phase (n = 3) and from atrophic endometrium (n = 1), demonstrating that our culture conditions can be used for tissue throughout the menstrual cycle, as well as pregnant and post-menopausal endometrium (Fig. 1f) . The origin and characterization of established organoid cultures used for this study are summarized in Supplementary Table 1 .
The established organoids can be expanded at passage ratios of 1:2 or 1:3 every 7-10 days for >6 months (reaching more than a 10 6 -fold increase in the number of organoids). Markers of glandular epithelium (MUC1, E-cadherin, CK7 and EPCAM) are strongly expressed by the organoids (Fig. 1g,h,i) . EPCAM and laminin are present at the baso-lateral membrane, showing that epithelial polarity is intact (Fig. 1i) . EdU pulse-labelling shows that ∼30% of cells are actively replicating (Fig. 1i) . The organoids form cystic structures lined by columnar epithelium with secretions visible in the lumen. Electron microscopy reveals a microvillus, pseudostratified columnar epithelium supported by amorphous basement membrane material with basally located nuclei (Fig. 1j) . The cytoplasm contains plentiful rough endoplasmic reticulum and Golgi bodies, numerous secretory vesicles, with evidence of secretory activity from the apical surface (Fig. 1k, arrowheads) . A major component of endometrial glandular secretions, glycogen, was visualized by vivid periodic acid Schiff (PAS) staining (Fig. 1l) . Thus, the appearances are highly similar to endometrial glands in vivo 27 . Next, the chromosomal stability of our endometrial organoids was checked by the Comparative Genomic Hybridization (CGH) array. Genomic DNAs were compared between the patient and established organoid cultures at early passage (p) (2-4p) and between early and late cultures (8-15p) ( Supplementary Fig. 1d-f) . No significant DNA copy number abnormalities were identified during derivation or after continuous passaging for up to 5 months. These organoids can be frozen, thawed and regrown, allowing bio-banking of human endometrial cultures.
Established human endometrial gland organoids recapitulate molecular signature of glands in vivo
To assess the similarity between organoids and the tissue of origin, we analysed the global gene expression profiles from established organoid lines (n = 7), initial glandular digests, and cultured stromal cells from the same biopsy. Staining for MUC1 (glands) and vimentin (stroma) confirmed enrichment of glands in our isolates and the purity of stromal cultures ( Supplementary Fig. 2a-d) . Hierarchical clustering analysis based on 15,475 probes (s.d./mean >0.1) shows that the organoid cultures cluster more closely to glands than to stroma, confirming their glandular epithelial nature (Fig. 2a) .
To define an endometrial glandular genetic signature, we compared glands and organoids to stroma. Two hundred and eighty-seven genes were commonly upregulated in organoids and glands compared with stroma with a fold change of ≥1.5 (P ≤ 0.01) (Fig. 2b) . Gene ontology (GO) analysis shows enrichment for 'epithelial identity' and 'glandular function' (Fig. 2c,d ). Markers of epithelial cells (CDH1, CLDN10 and EPCAM), mucosal secretory cells (PAX8 and MUC1) and of uterine glandular products were all present (PAEP, KLK11 and MUC20) (Fig. 2e) . Murine genes involved in endometrial glandular development and function (FoxA2, Sox17 and Klf5) also emerged 4, [28] [29] [30] [31] . Using immunohistochemistry, we verified nuclear presence of FOXA2, SOX17 and PAX8 in all organoids and endometrial glandular cells throughout the cycle (Fig. 2f) . Markers (PROM1, AXIN2 and LRIG1) common to other epithelial progenitor cells 32, 33 were found (Fig. 2e ), but in endometrium LRIG1 transcripts are present in glands and luminal epithelium throughout the cycle and so their significance is uncertain ( Fig. 2g and Supplementary  Fig. 3a) . Analysis of expression of other putative endometrial stem cell markers, AXIN2 and SSEA-1 was inconclusive 11 . Although AXIN2 transcripts were found in glands in vivo, lack of a reliable antibody prevented further analysis ( Supplementary Fig. 3b) . Only a few cells were SSEA-1 + in organoids, analysed by immunohistochemistry and flow cytometry (2-3%) and, after sorting SSEA-1 +/− cells, organoids emerged from the SSEA-1 − fraction ( Supplementary  Fig. 3c,d ). Overall the gene signature of decidual organoids (n = 6) is also very similar to non-pregnant endometrium (Supplementary
Epithelial cell differentiation Apart from shared gene sets between glands and organoids, there are also genes expressed only in glands (421/652) or organoids (286/484) ( Supplementary Fig. 5 ). GO terms for glands describe stromal interactions (integrin binding and extracellular matrix structural constituents), all absent in vitro. For organoids, in vitro proliferation (cell division and mitotic nuclear division) dominated. Thus, differential gene expression between gland samples and organoids reflects their contrasting microenvironments.
A converse analysis to define a stromal cell signature (Supplementary Fig. 2e ) revealed minimal contamination from endothelial cells (CD31 or CD34) or leukocytes (CD45). GO analysis showed 'biological processes' typical of fibroblasts and 'molecular functions' ( Supplementary Fig. 2f,g ). Gene sets were enriched for stromal cell markers (THY1, NT5E and IFITM1) 34, 35 , extracellular matrix proteins (COL8A1, COL12A1, COL13A1 and LAMA1), and metalloproteinases (MMP11, MMP2, MMP12, MMP27, MMP3, TIMP2 and CTGF) ( Supplementary Fig. 2e ). Genes encoding for components of WNT (WNT2, WNT5A, RSPO3), BMP (BMP2, GREM1) and MAPK (FGF2) signalling pathways also emerged, pathways identified from our culture conditions.
Human endometrial gland organoids respond to sex hormones
Unlike other mucosal epithelia, the endometrium responds dramatically to ovarian hormones, oestrogen (E2) and progesterone (P4), which regulate cyclical proliferation and differentiation of endometrial glands with concomitant dynamic temporal and spatial expression of their receptors, ERα and PR (Fig. 3a ) [36] [37] [38] . Following menstruation, glands increase expression of ERα in response to rising E2 levels (proliferative phase). After ovulation, ERα expression declines in the early secretory phase whereas PR is maintained until the mid-secretory phase (LH+7), after which both ERα and PR expression disappears 37 .
To mimic the response of the organoid cultures to hormones, we exposed organoids to E2 followed by P4 (Fig. 3b) . Under ExM conditions most cells show weak expression of ERα (ERα low ) with some ERα high ( Fig. 3c , arrowheads) and ERα − cells (Fig. 3c , arrows) present. Although most organoids are PR − , a few cells are PR high ; on serial sections these are also ERα high . After exposure to E2 and P4, high expression of both ERα and PR is seen in most organoids similar to the situation in vivo (Fig. 3c) . Organoid cultures derived from decidua showed similar responses ( Supplementary Fig. 6a ).
We performed a microarray analysis of organoids in ExM, E2 alone or E2 and P4. Known genes upregulated by E2 and P4 in the midsecretory phase 17 βHSD2, PAEP, SPP1, LIF, IGFBP4, IGFBP5 and CYCLIN A1 were all upregulated in hormonally treated organoids (Fig. 3d ) [39] [40] [41] [42] . This was confirmed for several genes using quantitative real-time PCR (qRT-PCR) (Fig. 3e) and at the protein level for PAEP and SPP1 (Fig. 3f,g ). We also confirmed that the addition of cyclic adenosine monophosphate (cAMP) to the differentiation medium, a component used typically in decidualization protocols, enhances the expression of differentiation markers shown by increased expression of PAEP and SPP1 ( Supplementary Fig. 6b ) 43 .
Other hormonally regulated endometrial genes emerged, including OLFM4, an intestinal stem cell marker 44 . In ExM, organoid cells were OLFM4-negative but a subset became OLFM4 + after E2 treatment, similar to the proliferative phase in vivo (Fig. 3h, arrows) . Collagen 1A2 (COL1A2), chromogranin A (CHGA) and OVOL2 were also upregulated, whilst HES1 and SOX9 were downregulated. In summary, the phenotypic response of glandular endometrial organoids to ovarian sex hormones is characteristic of the early-midsecretory phase.
Signals from decidualized stroma and the placenta can further stimulate differentiation of human endometrial gland organoids If implantation occurs, the endometrium forms the true decidua of pregnancy in response to P4; decidualized stromal cells characteristically secrete prolactin (PRL) 45 . Both PRL and signals from the conceptus are likely to stimulate uterine gland activity in early pregnancy (Fig. 4a ) 46, 47 . To mimic pregnancy, we added placental hormones (chorionic gonadotropin, hCG and human placental lactogen, hPL) in combinations with PRL to ExM containing E2+P4+cAMP, referred to as differentiation medium (Fig. 4b) .
The three hormones together stimulate maximal production of PAEP and a hypersecretory morphology characteristic of decidual glands in vivo (Fig. 4c) . PRL has an additional effect by stimulating the formation of ciliated cells (identified by acetylated α-tubulin) (Fig. 4d) . Similar findings were obtained using conditioned media from stromal cells decidualized in vitro for 10 days (Supplementary Fig. 6c ). As ciliated cells are present in vivo only in the uterine luminal epithelium and in superficial glands, the organoids are undergoing both glandular and luminal differentiation.
SOX9, a marker of progenitor cells, is expressed in the base of endometrial glands in vivo and at high levels in the organoids 11, 48, 49 but is absent from decidual glands in vivo. Organoids cultured with both ovarian and pregnancy hormones undergo differentiation as SOX9 was downregulated (Fig. 4e) . Thus, appropriate hormonal stimulation induces organoids to acquire a decidual-like phenotype characteristic of early pregnancy.
Human endometrial organoids have clonogenic ability and are bipotent
To assess for stem cell activity, we measured clonogenic ability by plating single cells from established organoid cultures by limiting dilution; drops containing single cells were marked and followed by time-lapse photography. Some cells formed an entire organoid over 7-14 days; the rest either did not divide or formed small dying spheroids (Fig. 5a ). The organoid-forming efficiency of these cells was 2-4% with 100 cells per drop and ∼10-fold lower with 10 cells per drop (Supplementary Table 2 ). Single organoids can be expanded into clonal cultures and we now have grown 12 clonal lines from 5 independently derived organoids (Fig. 5b) . A single cell has bipotent ability as it could generate the two main endometrial cell types: secretory (PAEP + ) and ciliated (acetylated-α-tubulin + ) cells (Fig. 5c ). Formation of cilia was confirmed by electron microscopy (Fig. 5d) .
Organoid cultures can be derived from endometrial cancer
Endometrial cancer is the commonest gynaecological tumour. Organoids were derived from samples of tumours and the normal adjacent endometrium from post-menopausal women. The morphology of the organoids showsn in Fig. 6 resembles the primary tumour (FIGO grade I endometrioid carcinoma) showing pleomorphic cells with hyperchromatic nuclei and disorganized epithelium. In places, breaching of the basement membrane is obvious, and isolated cells are seen in the surrounding Matrigel. The organoids are positive for glandular markers such as MUC1 and SOX17, confirming their glandular origin. Table 5 . (f) Western blot for PAEP in organoids after hormonal stimulation. Levels of glycosylated and nonglycosylated PAEP increase following exposure to E2 and E2+P4+cAMP. Ponceau S staining (Ponc S) for loading control. Experiment repeated twice using endometrial organoids from two patients. Unprocessed original scans of blots are shown in Supplementary Fig. 7 . (g) Enzyme-linked immunosorbent assay for SPP1 production by endometrial organoids following exposure to hormones. Three independent experiments (donors 1-3). SPP1 secretion increases following exposure to E2 and further after E2+P4+cAMP. Source data in Supplementary Table 5 . (h) Immunohistochemistry for OLFM4 on organoids under ExM, ExM+E2 and ExM+E2+P4+cAMP, and proliferative and secretory endometrium. Scale bars, 50 µm (main image) and 10 µm (insets). Representative of two proliferative and two secretory endometrial tissues and organoids derived from three different patients. 
DISCUSSION
Here, we describe a robust chemically defined method for establishing genetically stable endometrial organoids from human non-pregnant endometrium and decidua that can be cultured long-term and recapitulate the molecular signature of endometrial glands in vivo. Several murine genes important for glandular development and function (Foxa2, Klf5 and Sox17 ) are also expressed. The organoids functionally respond to sex hormones, E2 and P4, and when further stimulated with pregnancy (hCG, hPL) and stromal cell (PRL) signals, acquire characteristics of gestational endometrium, synthesizing abundant PAEP (glycodelin) and SPP1 (osteopontin). PAEP and SPP1, components of glandular secretions, 'uterine milk' , provide histotrophic support to the trophoblast before the haemochorial placenta is established.
Clonal organoid cultures generated from a single cell contain cells with extensive proliferative capacity, and both ciliated and secretory cells. Their gene signature includes markers of epithelial stem cells, LRIG1, PROM1, AXIN2 and SOX9. Because we could generate SOX9-expressing organoids from non-proliferative, SOX9
− , differentiated secretory phase endometrium and decidua, the few SOX9 + cells present mainly in the basal layer might expand 11 . Alternatively, plasticity of endometrial cells allows SOX9
− differentiated cells to self-renew and reacquire SOX9 expression in our cultures. A similar reversion occurs in the liver, where non-Lgr5 + cells reacquire Lgr5 stem cell marker expression following tissue injury 50 . Although organoids have been established from human fallopian tube with differentiation into both ciliated and secretory cells, neither the dramatic cyclical changes in response to E2 and P4, nor the process of decidualization induced by pregnancy occurs in the fallopian tube, a mucosal surface contiguous to endometrium 21 . Furthermore, the crucial site of embryo attachment is the luminal surface of the endometrium.
Endometrial organoids can be maintained and expanded in ExM, recapitulating pathways essential for culturing organoids from other organs-the FGF-MAPK, WNT-R-spondin, BMP-Noggin and TGFβ signalling pathways 51 . The contribution of endometrial stromal cells to these signalling pathways is revealed from our microarray analysis showing stromal transcripts encoding R-spondin-3 and FGF2. Further refinement of the method to replace Matrigel with a chemically defined extracellular matrix would enhance the model in future 52 . The identity of the endometrial epithelial stem cells remains unknown although their presence is revealed by the long-term expansion and clonogenic activity of organoids, and we have defined the essential niche components for their maintenance.
We also recapitulate the glandular cyclical changes during the menstrual cycle triggered by sequential secretion of ovarian hormones, E2 and P4. Endometrial organoids acquire a differentiated phenotype characteristic of the mid-secretory phase, with upregulation of several genes (17 βHSD2, SPP1, LIF) expressed at this time. Other genes, such as OLFM4, that may play key roles in regulating gland cell proliferation and function during the cycle were also identified.
Besides the direct effect that E2 and P4 have on the glands, they also exert a paracrine effect via the stromal cells. Decidualized stroma secretes a wide range of proteins, including PRL whose function is unknown. Unlike the pituitary, decidual PRL is driven from an alternative promoter, derived from transposable elements (MER20) 53 .
Our finding that addition of PRL induces ciliated cells suggests that it may influence differentiation and function of the glands.
The glands of gestational endometrium continue to differentiate and display a hypersecretory appearance with abundant PAEP production 54, 55 . In our organoid system, addition of trophoblast hormones (hCG and hPL) resulted in a similar appearance. This culture system will therefore allow further investigation of the essential (but understudied) period of histotrophic nutrition in the first trimester of pregnancy before the haemochorial placenta is established. Additionally, we were able to derive organoids from endometrial adenocarcinomas. These common tumours in postmenopausal women are associated with increased exposure to oestrogen that is a feature of obesity, nulliparity, treatment with tamoxifen and late menopause 56 . These can be used in the future to build a biobank to screen drugs and investigate the mutational changes, as has been done for colon cancers 57 . In summary, we describe a method for reliable chemically defined, long-term culture of endometrial glands from non-pregnant endometrium and decidua that closely recapitulates the molecular and functional characteristics of their cells of origin. The organoid cultures can be frozen down without loss of their proliferative ability after thawing, allowing the possibility to build up patient-specific bio-banks. This method will be an invaluable research tool to study new therapies for common pathologies of the endometrium, such as endometriosis and endometrial cancer, as well as investigating problems of implantation and the secretion of uterine histotroph during early pregnancy.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper. Secretory phase (6 and 10 d after pre-ovulatory luteinizing hormone surge) endometrial samples were obtained from subjects recruited from the Implantation Clinic at University Hospitals Coventry and Warwickshire National Health Service Trust with ethical approval from NHS National Research Ethics-Hammersmith and Queen Charlotte's & Chelsea Research Ethics Committee (1997/5065). Endometrial biopsies were obtained using a Wallach Endocell sampler, starting from the uterine fundus and moving downward to the internal cervical ostium. None of the subjects were on hormonal treatments for at least 3 months prior to the procedure.
Proliferative and secretory endometrial samples were obtained from Addenbrooke's Hospital under ethical approval from the East of EnglandCambridge South Research Ethics Committee (08/H0305/40).
Endometrial carcinoma samples were obtained from Addenbrooke's Hospital Tissue Bank.
Proliferative and secretory human endometrial tissue sections for immunohistochemistry and in situ hybridization studies were available with research ethical committee approval (Lothian Research Ethics Committee: 10/S1402/59; 16/ES0007). Endometrial tissues were staged on the basis of standard histological criteria and circulating oestradiol and progesterone levels at the time of collection and no exogenous hormone exposure. +10%FBS+pen/strep (Sigma, P0781) +L-glutamine (Sigma, 25030-024) for several days and subsequent analysis. The sieves were inverted over a Petri dish and retained glandular elements were backwashed from the sieve membranes, pelleted by centrifugation and resuspended in ice-cold Matrigel (Corning, 536231) at a ratio of 1:20 (vol:vol). Twenty-microlitre drops of Matrigel-cell suspension were plated into 48-well plates (Costar, 3548), allowed to set at 37 • C and overlaid with 250 µl organoid Expansion Medium (ExM). See Supplementary Table 3 for ExM composition. The medium was changed every 2-3 d. Cultures were passaged by manual pipetting every 7-10 d. For freezing organoids, Matrigel was removed using Cell Recovery Solution (Corning, 354253) and organoids were resuspended in Recovery cell culture freezing medium (Thermo Fisher Scientific, 12648-010). A step-by-step protocol of the derivation and maintenance of human endometrial organoid cultures can be found at Nature Protocol Exchange 58 .
Isolation of glands
Organoid formation efficiency assays. Organoids were removed of Matrigel using Cell Recovery Solution and pipetted several hundred times before trypsinizing with TrypLE Express (Invitrogen, 12604-013). Cells were washed in medium and passed through a 40 µm cell strainer (Corning, 352340) to ensure single-cell suspension. Cells were diluted in trypan blue to exclude dead cells and counted using a haemocytometer. For the growth factor requirement experiment (Fig. 1e) , 5,000 cells were plated per 20 µl Matrigel drop into 48-well plate, per culture condition in triplicate. The number of organoids formed after 7 d was scored. For organoid formation efficiency assay (Supplementary Table 2 ), 100 cells or 10 cells were plated into 5 µl Matrigel drops into 96-well plates (Thermo Fisher Scientific, 167008) and overlaid with 100 µl medium. The number of organoids was scored after 10 d.
Single-cell organoid formation timecourse. Organoids were processed in the same way as for organoid formation efficiency assay. Cells were then plated using the limiting dilution assay technique to have approximately 1 cell per 2.5 µl Matrigel drop. The drops were plated onto gridded 35 mm ibidi glass-bottom dishes (Thermo Scientific, 81148) and overlaid with 1.2 ml of ExM. ExM was supplemented with 10 µM Y-27632 (Merck, 688000) for the first 3 d of culture. Drops were screened and the relative positions of the drops containing one cell were stored using the Axiovision image software V4.8 and cells were imaged in phase contrast every 2 d using the Zeiss Axiovert Z1 microscope and Axio Observer software.
Differentiation of endometrial organoids. For hormonal stimulation of organoids with β-oestradiol (E2, Sigma E4389), progesterone (P4, Sigma P7556) and 8-bromoadenosine 3 , 5 -cyclic monophosphate (cAMP, Sigma B7880), organoids were passaged routinely and after 4 d of growth in ExM, they were primed with 10 nM E2. After 48 h, medium was replaced with the following conditions: untreated (ExM); 10 nM E2; or 10 nM E2 + 1 µM P4 + 1 µM cAMP. After 96 h, the organoids were collected for downstream applications. For differentiation of organoids using human pregnancy hormones, 20 ng ml −1 prolactin (PRL, Peprotech 100-07), 1 µg ml −1 human chorionic gonadotropin (hCG, Source Bioscience ABC403) and 20 ng ml −1 human placental lactogen (hPL, R&D 5757-PL) were used. Organoids were passaged routinely and after 4 d in ExM, the medium was switched to differentiation medium (DM), which is ExM containing 10 nM E2 + 1 µM P4 + 1 µM cAMP. DM was added with a combination of HCG, hPL and/or PRL for another 8 d. See Supplementary Table 3 for further information.
Enzyme-linked immunosorbent assay. Organoids from nine wells of a 48-well plate were pooled and transferred onto three 35 mm ibidi µ-dishes (Thermo Scientific, 81156) thinly coated with Matrigel diluted 1:2 in DMEM/F12. Matrigel was removed with Matrigel cell recovery solution on ice for 1 h. Organoids were washed in DMEM/F12 and resuspended in 1.2 ml ExM. Organoid suspension (400 µl) was plated into each dish and incubated at 37 • C for 2 h to allow organoids to attach. Dishes were flooded with ExM and cultured for 2-4 d until complete monolayers of cells had grown out. Cells were then treated as described above for E2 and P4 stimulation. Supernatants were harvested after a further 96 h and centrifuged to remove any cellular material prior to concentrating to 250 µl with Vivaspin 2 concentrators (Generon, VS0291). Concentrated supernatants were stored at −80 • C until use. Human Osteopontin (SPP1) Platinum ELISA (eBioscience, BMS2066) was performed using 50 µl concentrated supernatant with 50 µl sample buffer in duplicate alongside double diluted human SPP1 standard as per the manufacturer's instructions. The concentration of SPP1 in the supernatants was calculated from the line formula of the standard plots using Microsoft Office Excel.
Immunohistochemistry. Tissue sections of 4 µm were cut from formalin-fixed paraffin wax-embedded human endometrial and decidual tissues and organoids. Prior to paraffin embedding, organoids were removed from Matrigel using Cell Recovery Solution, fixed in formalin (Sigma, F5554) and embedded into 1% agarose (Melford, MB1200). Sections were dewaxed with Histoclear (National Diagnostics, HS-200), cleared in 100% ethanol and rehydrated through gradients of ethanol to PBS. Heat-induced epitope retrieval (HIER) was performed in Access Revelation (AR) pH 6.4 buffer (A.Menarini, MP-607-PG1) or Access Super (AS) (A.Menarini, MP-606-PG1), at 125 • C in an Antigen Access pressure cooker unit (A.Menarini, MP-2008-CE). Sections were blocked with 2% serum (of species in which the secondary antibody was made) in PBS, primary antibody incubation was 30 min at room temperature or overnight at 4 • C and slides were washed in PBS. Biotinylated horse anti-mouse or goat anti-rabbit secondary antibody was used, followed by Vectastain ABC-HRP reagent (Vector, PK-6100) and developed with di-aminobenzidine (DAB) substrate (Sigma, D4168). Sections were counterstained with Carazzi's haematoxylin and mounted in glycerol/gelatin mounting medium (Sigma, GG1-10). Primary antibody was replaced with an equivalent concentration of mouse or rabbit IgG for negative controls. See Supplementary Table 4 for antibody information. Periodic acid Schiff (PAS) staining was performed on paraffin sections following standard protocols provided by Surgipath. Tissue sections were imaged using a Zeiss Axiovert Z1 microscope and Axiovision imaging software SE64 V4.8.
Immunofluorescence (IF) and confocal microscopy. Endometrial organoids were grown in 35 mm ibidi µ-dishes (Thermo Scientific, 81156). Organoids were incubated for 2 h at 37 • C in 10 µM EdU in ExM. Organoids were fixed in 4% PFA for 30 min at room temperature and washed several times in PBS. Cells were permeabilized for 30 min in 0.5% Triton/PBS. EdU staining was done using Click-iT EdU Alexa Fluor 594 Imaging Kit (Thermo Scientific, C10339) following the manufacturer's instructions. Organoids were washed in PBS and blocked in 5% GS/1%BSA in PBS for 40 min at room temperature. Primary antibodies were incubated in blocking buffer with 0.05% Triton at 4 • C overnight. For antibodies used, see Supplementary  Table 4 . Negative controls were prepared by omitting primary antibody and omitting EdU incubation. Organoids were washed 3 times for 15 min in PBS. Organoids were incubated for 3 h at room temperature in PBS with secondary antibodies (all from Thermo Fisher Scientific): Alexa Fluor 488 goat anti-mouse IgG1 (A21121), Alexa Fluor goat anti-rabbit 568 (A11011) or Alexa Fluor 647 (A21244) at 1:400 and DAPI (Sigma, D9542). Organoids were washed in PBS for 30 min 3 times, mounted in ibidi mounting medium (Thermo Fisher Scientific, 400241) and imaged using the ZEISS 700 Confocal microscope and ZEN Microscope Software.
Flow cytometry. Organoids were processed as described above in the 'Organoid formation efficiency assays' section to obtain single-cell suspensions. Cells were blocked in 1% FBS in DPBS without calcium and magnesium (Thermo Fisher Scientific, ×5, treated with 1% osmium ferricyanide at room temperature for 12 h, followed by 5 washes in deionized water . They were then treated with 2% uranyl acetate in 0.05 M maleate buffer (pH 5.5) for 12 h at room temperature, rinsed in deionized water and dehydrated in an ascending series of ethanol solutions from 70% to 100% treated twice with dry acetonitrile and infiltrated with Quetol epoxy resin. Images were taken in an FEI Tecnai G2 operated at 120 kV using an AMT XR60B digital camera running Deben software. For Fig. 5d , organoids were fixed in 0.5% glutaraldehyde in 0.2 M sodium cacodylate buffer (pH 7.2) for 30 min, washed in sodium cacodylate buffer, treated with reduced osmium tetroxide 1% OsO 4 , 1.5% potassium ferricyanide at room temperature for 60 min, washed in water, treated with 0.5% magnesium uranyl acetate at 4 • C for 16 h, dehydrated with ethanol rinsed in propylene oxide and embedded in Epon resin. Ultrathin sections were examined in an FEI Tecnai G2 TEM at 80 kV. Images were acquired with a MegaView III CCD and Soft Imaging Systems program.
Western blotting analysis. Organoids were incubated in Matrigel cell recovery solution on ice for 1 h to remove Matrigel, washed in ice-cold PBS and resuspended in ice-cold buffer containing 20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM glycerolphosphate, 1 mM Na 3 VO 4 and complete mini proteases inhibitor cocktail (Roche, 04693159001). Western blots were performed as previously described 59 . Equivalent amounts of protein were resolved by SDS-PAGE, and transferred onto nitrocellulose membranes. Membranes were blocked in 5% milk in TBST for 1 h at room temperature and then incubated overnight at 4 • C with anti-PAEP antibody (Abcam, ab53289) diluted in 5% milk/TBST at 1:1,000. The membranes were analysed by enhanced chemiluminescence (GE Healthcare, RPN2106) using Kodak X-OMAT film (Sigma, F1274).
DNA extraction and quantification. DNA was extracted from donor patients' blood, endometrial biopsies, decidual tissue and organoids using QIAamp DNA blood Mini kit (Qiagen) by digestion with ATL buffer (Qiagen, 19076) and Proteinase K (Sigma, P4850), followed by purification steps with RNase A (Sigma, R6513) and Protein Precipitation Solution (Qiagen, 158910), precipitation with isopropanol and washing with 70% ethanol. DNA quality and concentration were determined using the Nanodrop ND-1000 Spectrophotometer.
Genetic analysis. The DNA was analysed using the Agilent Sureprint G3 unrestricted CGH ISCA 8 × 60 K array (Agilent, G4450A) by the Medical Genetics Laboratory at Addenbrooke's Hospital. Five independent organoid samples were analysed and DNA from patient's blood, biopsied tissue or early passage organoids was used as hybridization controls. DNA was diluted to 50 ng µl −1 and labelled using the Agilent kit following the manufacturer's instructions. Data analysis for segmentation and copy number calls was performed at a genome-wide resolution of 500 kb using the default analysis method-CGH v2 from the Agilent CytoGenomics software Edition 2.5.8.11 (Build 37).
RNA extraction, quantification and cDNA synthesis. Total RNA was extracted using the RNeasy Mini kit with on column DNAse treatment (Qiagen, 79254), following the manufacturer's instructions. RNA quality and concentration were determined using the Nanodrop ND-1000 Spectrophotometer. Total RNA (500 ng-1 µg) was reverse transcribed using Superscript VILO Reverse Transcriptase (Thermo Fisher Scientific, 11754050) with random hexamers and RNAse inhibitor according to the manufacturer's instructions. An RNA sample without reverse transcriptase was used as a control for genomic DNA contamination.
Real-time PCR. Quantitative real-time PCR (qRT-PCR) was performed on a 7900HT Fast Real-Time PCR system (Applied Biosystems) using Fast Taqman Mix and Taqman gene expression assays and following the manufacturer's protocol. The cycling conditions are: 95 • C for 20 s and 40 cycles of 95 • C for 3 s followed by 60 • C for 30 s. TaqMan Gene expression assays (Applied Biosystems) used: LIF (Hs01055668_m1), PAEP (Hs01046125_m1), SPP1 (Hs00959010_m1) and HSD17B2 (Hs00157993_m1). Expression levels were calculated applying the comparative Cycle threshold (Ct) method. Relative expression levels were normalized to the geometric mean of three housekeeping genes HPRT1 (Hs02800695_m1), TOP1 (Hs002432257_m1) and TBP (Hs00427620_m1) using Microsoft Office Excel. All qRT-PCR experiments were carried out with a non-template control.
Microarray expression profiling and data analysis. Microarray experiments were performed using the HumanHT-12 v4 Expression BeadChip (Illumina, BD-103-0204) according to the manufacturer's instructions by the Cambridge Genomic Services at University of Cambridge. A total of 7 endometrial samples were analysed and for each, the starting glandular digest, stromal cells and established organoids were used for analysis. Six organoid cultures derived from decidua were also analysed. RNA samples for microarray analysis were assessed for concentration and quality using a SpectroStar and a Bioanalyser. Briefly, 200 ng of Total RNA underwent linear amplification using the Illumina TotalPrep RNA Amplification Kit (Thermo Fisher Scientific, AMIL1791) following the manufacturer's instructions. The concentration, purity and integrity of cRNA were measured by SpectroStar and Bioanalyser. cRNA was hybridized to the HumanHT-12 v4 BeadChip overnight followed by washing, staining and scanning using the Illumina Bead Array Reader. After scanning, the data were loaded into GenomeStudio software. No background correction or normalization is applied at this stage. The data are processed in R using the lumi package and the limma package. Across all samples probes for which the intensity values were not significantly different (P > 0.01) from the negative controls were removed from the analysis. Following filtering the data were transformed using the Variance Stabilization Transformation (VST) from lumi and then normalized to remove technical variation between arrays using quantile normalization. Comparisons were performed using the limma package with results corrected for multiple testing using False Discovery Rate (FDR) testing. Finally, the quality of the data was assessed and the correlation of the samples in the groups compared. Heatmaps were generated using the heatmap.2 function of the R package 'gplots' , which uses the Euclidean method to obtain the distance matrix and the complete agglomeration method for clustering. For the sample heatmaps, the input is a correlation matrix based on samples' expression profile. For the gene heatmaps, the input is the vst transformed and normalized intensity matrix. The cluster analysis for the hormone stimulation microarray was done using the R sva package; expression values from all genes were transformed by removing the baseline differences between samples due to patient origin. Then, cluster analysis was done on a selected group of genes (those differentially expressed between control groups (ExM) and stimulated with oestrogen (ExM+E2) with adjusted P values ≤0.05) using the R stats package. The distance matrix was computed using 1-correlation as the distance measure, and hierarchical clustering was performed using the complete linkage method.
Statistics and reproducibility.
All experiments reported in this study have been reproduced with similar results using independent samples (tissues and organoids) from multiple patients. The origin of derivation of organoids (proliferative or secretory endometrium, decidua, post-menopausal or carcinoma) and the number of times the experiments were repeated are reported in the figure legends and summarized in Supplementary Table 1 . Given the descriptive nature of the work and biological variation between human samples, the experimental data points for each patient sample are shown separately unless stated otherwise. Statistical analyses used to analyse microarray data are reported in the Methods above and in the figure legends.
Data availability. Microarray data that support the findings of this study have been deposited in the Gene Expression Omnibus (GEO) under accession codes GSE83281 ( Fig. 2 and Supplementary Fig. 2 ) and GSE94723 (Fig. 3) . Source data for Figs 1b,e and 3e,g and Supplementary Fig. 6b have been provided as Supplementary Table 5 . All other data supporting the findings of this study are available from the corresponding authors on reasonable request. (e) Analysis of genetic stability of cultures with CGH array. A representative whole-genome array CGH plot generated using Agilent Cytogenomics software. Genomic DNA from early passage (p2) endometrial organoids (red) is compared to genomic DNA from original sample (blue). Each spot is a single probe. Log ratios of the average signal intensity of each probe on the Y-axis along its position on the chromosomes (1-22, X and Y) on the x-axis. A log signal ratio of 0 represents equivalent copy number. High signal in the Y chromosome region is not significant, and is due to absence of the Y chromosome in the samples. Repeated with 4 different decidual organoids and 2 endometrial organoids. (f) Genomic DNA from late passage (p8) endometrial organoids (red) compared to genomic DNA from early passage (p2) organoids (blue). The plot represents data described in the same way as in (e). Repeated with 4 different decidual organoids and 2 endometrial organoids. 
